Sign in
4

Changes in Ownership

Damora Therapeutics, Inc. Filed Acc 0001193125-26-124455

Options or other derivatives

  • Director acquired 37,313 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Bruno Julianne Director 2026-03-23 Grant or award · Stock Option (right to buy) +37,313 37,313 D
Loading xslF345X06/ownership.xml…